Response to Deng et al.'s LRRK2 patent review: Expert Opinion on Therapeutic Patents: Vol 23, No 2

643

Views

CrossRef citations to date

Altmetric

"Response to Deng et al.'s LRRK2 patent review." Expert Opinion on Therapeutic Patents, 23(2), p. 279

Declaration of interest

The author of this letter is an employee of Genentech, Inc. The author declares no other conflict of interest and has received no payment in preparation of this correspondence.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Response to Deng et al.'s LRRK2 patent review

Information for

Open access

Opportunities

Help and information

Response to Deng et al.'s LRRK2 patent review

Declaration of interest

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature